Also available in Persian — نسخه فارسی ✈️ Telegram EN فا
❓ Unknown

First-in-human trial of focused ultrasound aims to reduce schizophrenia-related hallucinations

Just now November 3, 2026 1 min read 📰 Medical Xpress
📋 Key Takeaway

A first-in-human clinical trial using focused ultrasound to reduce auditory hallucinations in schizophrenia has begun, addressing a significant need for new treatments as 40% of patients remain affected despite existing medications. This trial could offer hope for many individuals in Iran suffering from this condition.

🔍 Quick Context Guide
💡 Bottom Line: The trial represents a potential breakthrough in treating persistent auditory hallucinations in schizophrenia.

👥 Key Players

Researchers and medical professionals conducting the trial MENTIONED
Lead investigators and clinical trial staff
"They are crucial in developing new treatment options for schizophrenia, which affects many in Iran."
Patients with schizophrenia MENTIONED
Participants in the trial
"They represent a significant portion of the population suffering from treatment-resistant symptoms."

📰 What Happened

A clinical trial has begun to test focused ultrasound as a treatment for auditory hallucinations in schizophrenia. This innovative approach aims to help the 40% of patients who do not respond to existing medications.

  • Over 70% of people with schizophrenia experience auditory hallucinations.
  • Approximately 40% of these patients continue to suffer from hallucinations despite antipsychotic treatment.

💡 Why It Matters

🇮🇷 For Iran: This trial could provide new hope for many Iranians suffering from schizophrenia, addressing a critical gap in mental health treatment.
🌍 Regional: Improved mental health treatments could influence regional healthcare practices and policies.
🌐 International: Success in this trial may attract international attention and funding for mental health research.

📚 Background

Schizophrenia is a severe mental disorder characterized by hallucinations and delusions, affecting millions worldwide. Current treatments are not effective for all patients, highlighting the need for innovative therapies.

Mental health treatment advancements Schizophrenia and its societal impact
📡 Source: NEUTRAL
📊 Confidence: 70%
The article presents factual information about the clinical trial without evident bias.

Auditory hallucinations—or hearing voices that others do not hear—affect more than 70% of people with schizophrenia. Despite treatment with antipsychotic medications, approximately 40% continue to experience persistent hallucinations. For these patients, new treatment approaches are urgently needed.

🏷️ Entities Mentioned

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 100%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →